In a message dated 4/23/2002 10:42:49 AM Central Daylight Time, 
[email protected] writes:


> The following quotations have been attributed to Roger
> Altman, which I found too hard to ignore.
> 
> “I estimate that no more than 16 ounces of colloidal
> silver, or silver chloride, at a concentration of 5
> ppm should be ingested within 24 hours, or 64 ounces
> within 10 days. In addition, the ingestion of
> colloidal silver and/or silver chloride should be
> stopped for at least 5 days following any period of
> heavy consumption to lower the risk of argyria.”
> 
> He estimates this, based on what? He appears to be
> operating on the assumption that any kind of silver,
> if taken in enough quantity, will cause argyria. In
> spite of numerous reports of people ingesting far
> greater quantities of CS than he is cautioning about
> (up to 1-gallon per day of 10 ppm for years), he is
> cautioning at such a conservative level as to be
> ridiculous.
> 
> “Selenium binds with heavy metals, including silver.”
> 
> Any references to substantiate this?
> 
> “As the body eliminates these metals, it eliminates
> selenium along with them.”
> 
> References, please. Opinion has very little weight
> without substantiation.
> 

I think this is where his references came from.... 
<A HREF="http://www.epa.gov/iris/subst/0099.htm";>IRIS Summary -- Silver</A>  
http://www.epa.gov/iris/subst/0099.htm 

Below is just one example of the studies the U.S. EPA health scientists 
did on this site....

__I.A.4. Additional Studies/Comments (Oral RfD)

In the study by East et al. (1980) (see section 1.A.2.), one human was found 
to retain 18% of a single oral dose. However, the authors acknowledge that 
this high level of retention is not consistent with data published in other 
laboratories. For ethical reasons, the experiment could be not repeated to 
determine the validity of the results. 

Humans are exposed to small amounts of silver from dietary sources. The oral 
intake of silver from a typical diet has been estimated to range from 27-88 
ug/day (Hamilton and Minski, 1972/1973; Kehoe et al., 1940). Tipton et al. 
(1966) estimated a lesser intake of 10-20 ug/day in two subjects during a 30- 
day observation period. Over a lifetime, a small but measurable amount of 
silver is accumulated by individuals having no excessive exposure. Gaul and 
Staud (1935) estimated that a person aged 50 years would have an average 
retention of 0.23-0.48 g silver (equivalent to 1-2 g silver arsphenamine). 
Petering et al. (1991) estimated a much lower body burden of 9 mg over a 50- 
year period based on estimated intake, absorption, and excretion values; 
however, it is not clear how the final estimate was calculated. Furchner et 
al. (1968) studied the absorption and retention of ingested silver (as silver 
nitrate, amount not specified) in mice, rats, monkeys and dogs. In all four 
species, very little silver was absorbed from the GI tract. Cumulative 
excretion ranged from 90 to 99% on the second day after ingestion, with <1% 
of the dose being retained in <1 week in monkeys, rats and mice. Dogs had a 
slightly greater retention. The authors used the data from the dog to 
estimate how much silver ingested by a 70 kg human would be retained. An 
"equilibrium factor" of 4.4% was determined by integrating from zero to 
infinity a retention equation which assumes a triphasic elimination pattern 
for silver with the initial elimination of 90% coming from the dog data. The 
first elimination half-time of 0.5 days was used "arbitrarily"; subsequent 
half-times of 3.5 days and 41 days were taken from a metabolic study by 
Polachek et al. (1960). Furchner et al. (1968) considered their calculated 
equilibrium factor of 4.4% to be a conservative estimate for the amount of 
silver which would be retained by a 70 kg human. This figure was rounded to 
4% and was used in the dose conversion (i.v. dose converted to oral intake) 
for the calculation of the RfD. 

In addition to silver arsphenamine, any silver compound (silver nitrate, 
silver acetate, argyrol, Neosilvol and Collargol, etc.), at high dose, can 
cause argyria. Another important factor predisposing to the development of 
argyria is the exposure of the skin to light. 

Argyria, the critical effect upon which the RfD for silver is based, occurs 
at levels of exposure much lower than those levels associated with other 
effects of silver. Argyrosis, resulting from the deposition of silver in the 
eye, has also been documented, but generally involves the use of eye drops or 
make-up containing silver (Greene and Su, 1987). Silver has been found to be 
deposited in the cornea and the anterior capsule of the lens. The same 
deposition pattern was seen in the eyes of male Wistar rats following 
administration of a 0.66% silver nitrate solution to the eyes for 45 days 
(Rungby, 1986). No toxicological effects were reported. 

Toxic effects of silver have been reported primarily for the cardiovascular 
and hepatic systems. Olcott (1950) administered 0.1% silver nitrate in 
drinking water to rats for 218 days. This exposure (about 89 mg/kg/day) 
resulted in a statistically significant increase in the incidence of 
ventricular hypertrophy. Upon autopsy, advanced pigmentation was observed in 
body organs, but the ventricular hypertrophy was not attributed to silver 
deposition. 

Hepatic necrosis and ultrastructural changes of the liver have been induced 
by silver administration to vitamin E and/or selenium deficient rats (Wagner 
et al., 1975; Diplock et al., 1967; Bunyan et al., 1968). Investigators have 
hypothesized that this toxicity is related to a silver-induced selenium 
deficiency that inhibits the synthesis of the seleno-enzyme glutathione 
peroxidase. In animals supplemented with selenium and/or vitamin E, exposures 
of silver as high as 140 mg/kg/day (100 mg Ag/L drinking water) were well- 
tolerated (Bunyan et al., 1968).